Cite
HARVARD Citation
Norin, S. et al. (n.d.). Severe infusion-related reactions are uncommon in rituximab-treated CLL patients in clinical practice: Results from a Swedish national observational study. Leukemia research. 39 (1), pp. 33-37. [Online].